Latest Breaking News On - Ts farn fi4000153309 - Page 1 : comparemela.com

FINLAND - Faron Pharmaceuticals Oy , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the release of further insights from its Phase. | April 25, 2023

Maija hollmenJennifer smith parkerFaron pharmaceuticals oyFirst northChief scientific officerCommon lymphatic endothelialVascular endothelial receptorNews publishingFaron pharmaceuticals oy stock exchangePress releaseTs farn fi4000153309